BMRN Stock Summary and Trading Ideas (Biomarin Pharmaceutical | NASDAQ:BMRN)

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

What symbol and exchange does Biomarin Pharmaceutical shares trade?

Biomarin Pharmaceutical trades on the NASDAQ stock market under the symbol BMRN.

What is Biomarin Pharmaceutical stock price doing today?

As of August 21, 2026, BMRN stock price declined to $66.70 with 1,365,891 million shares trading.

What is Biomarin Pharmaceutical's Beta?

BMRN has a beta of 0.50, meaning it tends to be less sensitive to market movements. BMRN has a correlation of 0.05 to the broad based SPY ETF.

How much is Biomarin Pharmaceutical worth?

BMRN has a market cap of $12.89 billion. This is considered a Large Cap stock.

How much money does Biomarin Pharmaceutical make?

Last quarter Biomarin Pharmaceutical reported $990 million in Revenue and $1.20 earnings per share. This beat revenue expectation by $59 million and exceeded earnings estimates by $.28.

What is the highest and lowest price Biomarin Pharmaceutical traded in the last 3 year period?

In the last 3 years, BMRN traded as high as $99.56 and as low as $49.26.

What are the top ETFs holding Biomarin Pharmaceutical?

The top ETF exchange traded funds that BMRN belongs to (by Net Assets): IJH, VTI, VB, VBK, VXF.

Is Biomarin Pharmaceutical (BMRN) a good investment?

BMRN has underperformed the market in the last year with a return of +14.9%, while SPY returned +21.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in BMRN shares. However, BMRN has outperformed the market in the last 3 month and 2 week periods, returning +23.3% and +4.5%, while SPY returned +3.4% and -1.0%, respectively. This indicates BMRN has been having a stronger performance recently.

What are the support and resistance levels for Biomarin Pharmaceutical (BMRN)?

BMRN support price is $66.23 and resistance is $69.13 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BMRN shares will trade within this expected range on the day.